Ionctura

Developer of pharmaceuticals to treat cancer

placeGeneva, Geneva, Switzerland calendar_todayFounded 2017 groups20 employees language ionctura.com

Registered entities

Social engagement

Social engagement: 6.7K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include VI Partners, Inkef, Syncona, 3B FUTURE Health Fund.

Investor typeCountShare
Venture capital655%
Accelerator & incubator327%
Other / undisclosed218%

Recent activity

2 Jul 2026
Event
ESMOGI26
25 Jun 2026
Event
Fast-tracking Biotech Innovation in Europe: Incentives and Funding panel at BIO2026
23 Jun 2026
Event
Breaking New Ground: The Promise and Challenges of First-in-Class Therapies
Coming soon